Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations

Recruiting Observational Study
PTEN ASD Autism Macrocephaly PTEN Hamartoma Tumor Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 Months and older
Sex
Any
Study type
Observational
Participants needed
170 (estimated)
Sponsor
Boston Children's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to determine cross-sectional and longitudinal medical, behavioral, and cognitive differences between PTEN ASD and other groups, as well as to identify cognitive, neural systems, and molecular biomarkers specific to PTEN ASD. In addition, this study will be creating and maintaining a biorepository and linked phenotypic database for PTEN ASD.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Individuals above the age of 18 months old at the time of consent who have documentation of a clinical diagnosis of autism spectrum disorder and/or a verified PTEN mutation from a medical or mental health professional for inclusion in the PTEN ASD, PTEN no-ASD or ASD macrocepha…
Contacts

Rajna Filip-Dhima, MS

617-919-7068

Rajna.Filip-Dhima@childrens.harvard.edu

CONTACT